Honored to be awarded with the Bonadonna Fellowship, to support my research on metabolism in breast cancer at DFCI/HMS. Very grateful to @FondazioneBona1, @AIRC_it, #PradaGroup & my mentors Dr. Vernieri, Prof. De Braud (@IstTumori) and Dr. Ligibel (@DFCI_BreastOnc @harvardmed)!

📢Happy to share our thoughts on E2 monitoring in premenopausal patients with eBC 🚨Data on patients with incomplete OFS from @IEOufficiale will be presented at @myESMO meeting 2025 by @JD_Etessami - stay tuned! - with @darioT_ @curijoey @elisabettasabet @GPravettoni

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body. The Nobel Prize laureates

We’re proud to announce that the Dana-Farber/Harvard Cancer Center has been awarded a $12 million, 5-year NIH SPORE grant renewal to advance #BreastCancerResearch! Under the leadership of Drs. Kornelia Polyak, Leif Ellisen, Nancy Lin, and Geoffrey Shapiro, this program brings

@DanaFarber staff, Jennifer Ligibel MD, Ting Bao, MD, MS, FSIO (@tingbao2011) and Christina Dieli-Conwright, PhD, MPH (@ChristinaDieli) recently participated in a panel discussion for @theNCI #IntegrativeOncology Working Group seminar series on #ExerciseOncology.

SG is a highly effective ADCs, and when used adequately, it saves lives. This includes careful management of toxicities, with prophylaxis when indicated. In this article we review the data & provide RW perspectives on the management of toxicities with SG. https://t.co/ACUZovlVS6

@DanaFarber's Dr. Jennifer Ligibel highlighted the impact of Diet, Exercise, and Lifestyle in #BreastCancer prevention, sharing exciting findings from new research at the @df_hcc Breast Cancer Research Retreat.

This recent study looked at the association between young age at #MetastaticBreastCancer diagnosis and overall survival in the #EMBRACE study. The study included 4000+ pts with de novo and recurrent #MBC and found that: 📌 Age ≤35 years at MBC diagnosis was associated with worse

Cats teach science.

The power of healing through art therapy. The @BostonGlobe highlight’s @danafarberZakim’s art therapy program, led by Megan Carleton. Read more:

APA Statement on White House Announcement on Autism https://t.co/S5bf8MycQu

Treating cancer means more than treating the disease A 3-session Meaning-Centered psychotherapy eased distress in advanced cancer: mental experts must be integral to care, together w/ oncologists and palliative teams

Nutrition advice on social media often goes viral for clicks, not credibility, impacting strongly our patients! ❌ Misinformation ❌ Extreme diets ✅ Engaging expert voices ✅ Media literacy ✅ Stronger regulation

Exciting new data from the BWEL trial on @JAMAOnc! A 2-year telephone-based lifestyle intervention achieved significant weight changes: -4.3 kg (-4.7%) at 1y vs +0.9 kg (+1.0%) in controls, among 3,180 women w/ stage II-III breast cancer and excess adiposity 🔗

The #DREPstudy led by @DFCI_BreastOnc aims to learn how exercise might lower the risk of developing #BreastCancer in women with #DenseBreastTissue by studying changes that occur in breast tissue and blood. For more information call 877-338-7425 or visit: https://t.co/syeg8Uj5Cg

We report initial observations on GLP1 RAs in breast cancer survivors: These meds at standard doses prevent weight gain & induce modest (4-6%) weight loss, particularly during hormone therapy. https://t.co/tfFq7zKnzZ @SherryShenMD @MSKCancerCenter @WinshipAtEmory @CancerNetwrk

✨ QoL improved not just fast… but FastER 🌙🏃‍♀️ 📖 FastER Pilot Trial | HR+ MBC 📰 Breast Cancer Research & Treatment, 2025 Population 👩‍🦰 Women with HR+ metastatic breast cancer 💊 Starting ET + CDK4/6i or alpelisib (n=31) Intervention (12 weeks) ⏳ Nightly fasting ≥13h, 6